- Home
- LVTX vs NXN Comparison
LVTX vs NXN Comparison
Compare LVTX & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- NXN
- Stock Information
- Founded
- LVTX 2016
- NXN 1992
- Country
- LVTX Netherlands
- NXN United States
- Employees
- LVTX N/A
- NXN N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- LVTX Health Care
- NXN Finance
- Exchange
- LVTX Nasdaq
- NXN Nasdaq
- Market Cap
- LVTX 40.0M
- NXN 47.3M
- IPO Year
- LVTX 2021
- NXN N/A
- Fundamental
- Price
- LVTX $1.64
- NXN $12.14
- Analyst Decision
- LVTX Hold
- NXN
- Analyst Count
- LVTX 4
- NXN 0
- Target Price
- LVTX $1.58
- NXN N/A
- AVG Volume (30 Days)
- LVTX 131.8K
- NXN 9.7K
- Earning Date
- LVTX 11-06-2025
- NXN 01-01-0001
- Dividend Yield
- LVTX N/A
- NXN 4.23%
- EPS Growth
- LVTX N/A
- NXN N/A
- EPS
- LVTX N/A
- NXN 0.24
- Revenue
- LVTX $4,990,000.00
- NXN N/A
- Revenue This Year
- LVTX N/A
- NXN N/A
- Revenue Next Year
- LVTX N/A
- NXN N/A
- P/E Ratio
- LVTX N/A
- NXN $48.42
- Revenue Growth
- LVTX N/A
- NXN N/A
- 52 Week Low
- LVTX $0.85
- NXN $10.64
- 52 Week High
- LVTX $2.00
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- LVTX 62.46
- NXN 54.75
- Support Level
- LVTX $1.60
- NXN $11.98
- Resistance Level
- LVTX $1.83
- NXN $12.17
- Average True Range (ATR)
- LVTX 0.07
- NXN 0.08
- MACD
- LVTX 0.01
- NXN -0.01
- Stochastic Oscillator
- LVTX 65.28
- NXN 56.67
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.